Ppar-(gamma) agonists as agents for the treatment of type ii diabetes
CA 2370742 A1 · Owner: Mcgeehan, Gerard · Inventors: Kolla, Laxma Reddy; Mcgeehan, Gerard; Cavallaro, Cullen
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are compounds of formula (I) or the pharmaceutically acceptable nontoxic salts thereof wherein: Z is aryl or heteroaryl; n and m are 0 1 or 2; A , is a carboxylic acid or ester; or A is formula (II) where D F and G are , hydrogen, (un)substituted amino (un)substituted alkoxy, methylene or an (un)substituted sulfide; X is N, O, CH2 S, SO or SO2; R4 is oxo, hydrogen, hydroxy lower alkyl, lower alkoxy, cycloalkyl, keto acyl, or sulfonyl; Y is , hydrogen, (un)substituted amino (un)substituted alkoxy, methylene, an (un)substituted sulfide, (un)substituted sulfonyl or an (un)substituted sulfoxide; and R5, R6 and R8 are hydrogen lower alkyl, lower alkoxy, cycloalkyl, keto acyl, or …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 18, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 18, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 18, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.